HOME >> MEDICINE >> NEWS
Penn researchers announce results of Phase I trial using combretastatin drug

(Philadelphia, PA) -- New approaches are needed to treat solid malignant tumors that cannot be removed surgically and are resistant to traditional powerful chemotherapy drugs. In a Phase I clinical trial, a team of researchers at the University of Pennsylvania Cancer Center has found that patients with solid cancerous tumors were able to safely tolerate a new drug, originally derived from a South African willow bush, that interacts with the tumor's blood supply. James P. Stevenson, MD, assistant professor of medicine at Penn and lead author of the study, will present these findings at the 91st American Association of Cancer Research Meeting on Tuesday, April 4, 2000 in San Francisco.

Combretastatin A4 phosphate is a drug that is classified as a vascular targeting agent. It selectively targets and reduces or destroys blood vessels supplying malignant tumors while sparing the vasculature of normal tissues. Vascular targeting agents like combretastatin attack proliferating blood vessels that already exist, whereas angiogenesis inhibitors generally stop new blood vessels from developing.

In this study, 29 patients with a range of solid tumors, unresponsive to traditional chemotherapy, were treated with a daily intervenous dose of combretastatin for five consecutive days every three weeks. All of the patients were given CT scans before and at the end of the treatment cycle to determine changes in tumor blood supply. Nine patients who were given the highest dose of combretastatin were monitored via MRI. Dr. Stevenson's team found evidence of a decrease in blood flow to the tumor following combretastatin therapy in five of the nine patients who were followed by MRI.

"These early results are promising and suggest that combretastatin may affect tumor blood supply," says Stevenson. "We will continue investigating this drug for its potential benefits in fighting advanced cancers."

T
'"/>

Contact: Sue Montgomery
sue.montgomery@uphs.upenn.edu
215-349-5657
University of Pennsylvania School of Medicine
3-Apr-2000


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... ... September 07, 2018 , ... Start your engines and race to the new ... which to choose. Pedal power is the name of the game here – whether ... left on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t be better ...
(Date:9/2/2018)... , ... September 01, 2018 ... ... is proud to add HydraFacial MD® Elite to its leading menu of ... patented, vortex-suction technology and an infusion of clinically-proven ingredients to dramatically improve ...
(Date:9/1/2018)... ... 31, 2018 , ... Alice Branton shared her personal story on NBC Daytime ... host Jerry Penacoli. , With all the medical advancements over the last hundred ... major public health problem worldwide irrespective of age, location, ethnicity, and gender. Even in ...
(Date:8/31/2018)... ... August 31, 2018 , ... Kessler Foundation, a ... of an MRI Simulator. In the MRI Simulator, the individual experiences the conditions ... this mock scan experience, research participants become accustomed to the sights and sounds ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, ... of a biofield energy treated nutraceutical to improve overall immunity and to combat ... and blood, as well as, inflammation. The following data was reported:, ...
Breaking Medicine News(10 mins):
(Date:8/31/2018)... , ... August 31, 2018 , ... The summertime sweat ... those who suffer from a condition known as hyperhidrosis. In Grand Rapids , ... out” as men and women alike frequently soak through their shirts for no reason ...
(Date:8/31/2018)... ... ... Travel tech specialist Aquarium Software has welcomed news that the Financial Conduct ... for the disabled. The move is an admission that some consumers continue to find ... living with a disability, Aquarium Software says thoughts now need to turn to how ...
(Date:8/31/2018)... ... 31, 2018 , ... San Francisco Dental Implant Center, the Bay Area's leading ... Oakland, California, specifically targeted at those who live across the Bay and are searching ... Area’ encompasses a wide area and can include many nearby cities and towns,” explained ...
Breaking Medicine Technology:
Cached News: